MELISIA MARTIN: Open Payments
NPI 1447427521 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,773 in 111 payments from 19 companies in 2025. Trend: 2023 $1,368 · 2024 $1,393 · 2025 $1,773
Food & beverage: $1,773
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $462 |
| ABBVIE INC. | 24 | $285 |
| PFIZER INC. | 18 | $158 |
| Corcept Therapeutics | 4 | $156 |
| Amgen Inc. | 16 | $135 |
| Axsome Therapeutics, Inc. | 3 | $105 |
| Novartis Pharmaceuticals Corporation | 6 | $98 |
| Hologic Sales and Service, LLC | 1 | $93 |
| Lundbeck LLC | 3 | $73 |
| Astellas Pharma US Inc | 2 | $46 |
Products named: Wegovy, Ozempic, Korlym, NURTEC ODT, Symbravo, LEQVIO, UBRELVY, THINPREP 2000 PROCESSOR.
Industry payments across TX — which companies pay providers there.
